Salvatore Perrone

29PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 26, 2026
Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence.

|May 09, 2026
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.

|Apr 09, 2026
A case of T-prolymphocytic leukemia harboring RAS mutation.

Salvatore Perrone, Giada Pacitto, Alessia Tirnetta

|Mar 31, 2026
Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm.

Salvatore Perrone, Laura De Fazio, Sebastian Monachetti

|Feb 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Salvatore Perrone, Andrea Corbingi, Calogero Vetro

Pageof 5

Frequent Collaborators

9 joint publications

Matteo Molica

7 joint publications

Calogero Vetro

6 joint publications

Fabio Guolo

6 joint publications

Livio Pagano